FHIR IG analytics877 resources
By Authority
By Realm
Rows 0 - 200 Next
| Package | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Resource |
|---|---|---|---|---|---|---|---|---|---|
| hl7.fhir.pl.ssidl | ssidl-activityDefinition-labServiceDefinition | Definicja usługi laboratoryjnej w bazie wiedzy (SSIDL) | draft | 2025-08 | pl | hl7 | ActivityDefinition | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | body-positioning-action | Body Positioning Action | draft | 2022-09 | uv | hl7 | ActivityDefinition | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | drug-administration-action | Drug Administration Action | draft | 2022-09 | uv | hl7 | ActivityDefinition | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | procedure-action | Procedure Action | draft | 2024-05 | uv | hl7 | ActivityDefinition | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | recommendation-action | Recommendation Action | draft | 2021-12 | uv | hl7 | ActivityDefinition | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | assessment-action | Assessment Action | draft | 2023-11 | uv | hl7 | ActivityDefinition | ||
| hl7.fhir.uv.pharm-quality | ActivityDefinition-test-drug-pq | ActivityDefinition - Test Drug PQ | active | brr | 2024-05 | uv | hl7 | ActivityDefinition | |
| hl7.fhir.uv.order-catalog | LabProcedureDefinition | Laboratory Procedure Definition | trial-use | 2 | oo | 2025-06 | uv | hl7 | ActivityDefinition |
| silfhirprofileig | sghi-activitydefinition | SGHI Activity Defintion Profile | draft | 2025-07 | ActivityDefinition | ||||
| hl7.fhir.pl.ssidl | ssidl-activityDefinition-labCatalogService | Usługa katalogowa laboratorium (SSIDL) | draft | 2025-08 | pl | hl7 | ActivityDefinition | ||
| hl7.eu.fhir.unicom | PPLAdministrableProductDefinition | PPL Administrable Product profile | draft | 2025-06 | eu | hl7 | AdministrableProductDefinition | ||
| hl7.fhir.uv.emedicinal-product-info | AdministrableProductDefinition-uv-epi | AdministrableProductDefinition (ePI) | trial-use | 2 | 2025-07 | uv | hl7 | AdministrableProductDefinition | |
| hl7.eu.fhir.unicom | TransitionAdministrableProductDefinition | Processing Profile - Administrable Product | draft | 2025-06 | eu | hl7 | AdministrableProductDefinition | ||
| ch.fhir.ig.ch-epl | ch-idmp-administrableproductdefinition | CH IDMP AdministrableProductDefinition | active | 2025-05 | ch | hl7 | AdministrableProductDefinition | ||
| idmp.who-umc.org.fhir | AdministrableProductDefinition-who-php | AdministrableProductDefinition (WHO PhP) | active | 2025-06 | uv | AdministrableProductDefinition | |||
| hl7.fhir.uv.adverseeventclinicalcare | AdverseEvent-clinical-care | Adverse Event Clinical Care | informative | 1 | 2022-06 | uv | hl7 | AdverseEvent | |
| hl7.fhir.eu.imaging-manifest-r5 | ImAdverseEvent | Imaging Adverse Event | draft | 1 | 2025-07 | eu | hl7 | AdverseEvent | |
| hl7.fhir.eu.imaging-r5 | ImAdverseEvent | Imaging Adverse Event | draft | 1 | 2025-08 | eu | hl7 | AdverseEvent | |
| hl7.fhir.uv.ae-research-ig | AdverseEvent-clinical-research | Adverse Event Clinical Research | trial-use | 2 | brr | 2024-04 | uv | hl7 | AdverseEvent |
| hl7.fhir.eu.imaging-r5 | Report-ImAdverseEvent | Report obligations for ImAdverseEvent | draft | 2025-08 | eu | hl7 | AdverseEvent | ||
| hl7.fhir.eu.imaging-manifest-r5 | AllergyIntoleranceEu | EU AllergyIntolerance | draft | 1 | 2025-07 | eu | hl7 | AllergyIntolerance | |
| hl7.fhir.eu.imaging-r5 | AllergyIntoleranceEu | EU AllergyIntolerance | draft | 1 | 2025-08 | eu | hl7 | AllergyIntolerance | |
| hl7.fhir.cr.core | allergy-intolerance-cr-core | Alergias e Intolerancias | draft | 0 | cgp | 2025-03 | cr | hl7 | AllergyIntolerance |
| hl7.fhir.eu.imaging-r5 | Report-EuAllergyIntolerance | Report obligations for EuAllergyIntolerance | draft | 2025-08 | eu | hl7 | AllergyIntolerance | ||
| silfhirprofileig | sghi-allergyintolerance | SGHI AllergyIntolerance | draft | 2025-07 | AllergyIntolerance | ||||
| silth.fhir.th.mophpc1 | mophpc-allergyintolerance-base | MoPH-PC AllergyIntolerance | active | 2023-09 | AllergyIntolerance | ||||
| silfhirprofileig | sghi-appointment | SGHI Appointment Profile | draft | 2025-07 | Appointment | ||||
| hl7.at.fhir.tc.wg.scheduling.r5 | at-scheduling-appointment | HL7® AT Scheduling Appointment Profile | draft | 2025-05 | hl7 | Appointment | |||
| de.netzwerk-universitaetsmedizin.ebm-cpg | recommendation-justification | Recommendation Justification | draft | 2022-03 | uv | hl7 | ArtifactAssessment | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | certainty-of-evidence-rating | Certainty of Evidence Rating | draft | 2022-03 | uv | hl7 | ArtifactAssessment | ||
| hl7.fhir.cr.core | audit-event-cr-core | Auditoría de Eventos | draft | 0 | cgp | 2025-03 | cr | hl7 | AuditEvent |
| ca.on.health.idms | PROFILE-IDMS-AUDITEVENT | IDMS - AuditEvent | active | AuditEvent | |||||
| uz.dhp.core | uz-core-auditevent | UZ Core AuditEvent | active | 2025-03 | AuditEvent | ||||
| dhp | dhp-auditevent | Uzbekistan DHP AuditEvent | active | 2025-03 | AuditEvent | ||||
| ca.on.health.idms | PROFILE-BASIC-PRIMARY-FILE-NUMBER | IDMS - Basic - Primary File Number | draft | Basic | |||||
| ca.on.health.idms | 4122c217-8e94-40e9-a371-889fe73ada19 | IDMS_Binary | draft | 2021-09 | Binary | ||||
| hl7.fhir.eu.imaging-manifest-r5 | BodyStructureEu | EU BodyStructure | draft | 1 | 2025-07 | eu | hl7 | BodyStructure | |
| hl7.fhir.eu.imaging-r5 | BodyStructureEu | EU BodyStructure | draft | 1 | 2025-08 | eu | hl7 | BodyStructure | |
| hl7.fhir.uv.dicom-sr | dicom-sr-finding-site | Body Structure - DICOM SR Finding Site Mapping | active | ii | 2025-05 | uv | hl7 | BodyStructure | |
| hl7.fhir.uv.dicom-sr | dicom-sr-tracking-identifiers | Body Structure - DICOM SR Observation Tracking Identifier Mapping | active | ii | 2025-05 | uv | hl7 | BodyStructure | |
| hl7.fhir.eu.imaging-manifest-r5 | Manifest-EuBodyStructure | Manifest obligations for EuBodyStructure | draft | 2025-07 | eu | hl7 | BodyStructure | ||
| hl7.fhir.eu.imaging-r5 | Manifest-EuBodyStructure | Manifest obligations for EuBodyStructure | draft | 2025-08 | eu | hl7 | BodyStructure | ||
| hl7.fhir.eu.imaging-r5 | Report-EuBodyStructure | Report obligations for EuBodyStructure | draft | 2025-08 | eu | hl7 | BodyStructure | ||
| hl7.fhir.eu.base-r5 | bodyStructure-eu | BodyStructure (EU base) | draft | 2 | 2025-08 | eu | hl7 | BodyStructure | |
| hl7.fhir.us.spl | OrganizationBundle | OrganizationBundle | trial-use | 1 | brr | 2025-07 | us | hl7 | Bundle |
| hl7.fhir.us.spl | GDUFAFacilityIdentificationBundle | GDUFAFacilityIdentificationBundle | trial-use | 1 | brr | 2025-07 | us | hl7 | Bundle |
| hl7.fhir.us.spl | LabelerInactivationBundle | LabelerInactivationBundle | trial-use | 1 | brr | 2025-07 | us | hl7 | Bundle |
| hl7.fhir.us.spl | LabelerCodeRequestBundle | LabelerCodeRequestBundle | trial-use | 1 | brr | 2025-07 | us | hl7 | Bundle |
| hl7.fhir.us.spl | NoChangeNotificationBundle | NoChangeNotificationBundle | trial-use | 1 | brr | 2025-07 | us | hl7 | Bundle |
| hl7.fhir.us.spl | EstablishmentRegistrationBundle | EstablishmentRegistrationBundle | trial-use | 1 | brr | 2025-07 | us | hl7 | Bundle |
| hl7.fhir.us.spl | EstablishmentInactivationBundle | EstablishmentInactivationBundle | trial-use | 1 | brr | 2025-07 | us | hl7 | Bundle |
| hl7.fhir.us.spl | GDUFAFacilityInactivationBundle | GDUFAFacilityInactivationBundle | trial-use | 1 | brr | 2025-07 | us | hl7 | Bundle |
| hl7.fhir.us.spl | OutOfBusinessBundle | OutOfBusinessBundle | trial-use | 1 | brr | 2025-07 | us | hl7 | Bundle |
| hl7.fhir.us.spl | ProductSubmissionBundle | ProductSubmissionBundle | trial-use | 1 | brr | 2025-07 | us | hl7 | Bundle |
| hl7.fhir.uv.pharm-quality | Bundle-analytical-procedure-pq | Bundle – Analytical Procedure PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-batch-analysis-pq | Bundle – Batch Analysis PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-batch-formula-pq | Bundle – Batch Formula PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-product-batch-info-pq | Bundle – drug Product Batch Information PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-substance-batch-info-pq | Bundle – Drug Substance Batch Information PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| de.netzwerk-universitaetsmedizin.ebm-cpg | guideline-bundle | Guideline Bundle | draft | 2022-12 | uv | hl7 | Bundle | ||
| hl7.fhir.uv.pharm-quality | Bundle-drug-product-compatibility-pq | Bundle - Drug Product Compatibility PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-reference-standards-pq | Bundle – Drug Reference Standards PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-product-composition-pq | Bundle – Drug Product Composition PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-container-closure-system-pq | Bundle – Container Closure System PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32p10 | CMC eCTD 32P10 Document | trial-use | 2 | brr | 2025-07 | us | hl7 | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32p32 | CMC eCTD 32P32 Document | trial-use | 2 | brr | 2025-07 | us | hl7 | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32p55 | CMC eCTD 32P55 Document | trial-use | 2 | brr | 2025-07 | us | hl7 | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32s10 | CMC eCTD 32S10 Document | trial-use | 2 | brr | 2025-07 | us | hl7 | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32s23 | CMC eCTD 32S23 Document | trial-use | 2 | brr | 2025-07 | us | hl7 | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32s3 | CMC eCTD 32S3 Document | trial-use | 2 | brr | 2025-07 | us | hl7 | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-sp4151 | CMC eCTD SP4151 Document | trial-use | 2 | brr | 2025-07 | us | hl7 | Bundle |
| hl7.fhir.eu.imaging-manifest-r5 | ImReport | Document Bundle for Imaging Report | draft | 1 | 2025-07 | eu | hl7 | Bundle | |
| hl7.fhir.eu.imaging-r5 | ImReport | Document Bundle for Imaging Report | draft | 1 | 2025-08 | eu | hl7 | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-product-pq | Bundle - Drug Product PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-product-microbiological-attributes-pq | Bundle – Drug Product Microbiological Attributes PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-product-excipients-pq | Bundle – Drug Product Excipients PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-substance-general-properties-pq | Bundle – Drug Substance General Properties PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-substance-characterization-pq | Bundle – Drug Substance Characterization PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-product-impurities-pq | Bundle - Product Impurities PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.eu.imaging-manifest-r5 | Manifest-ImImagingStudyManifest | Manifest obligations for ImImagingStudyManifest | draft | 2025-07 | eu | hl7 | Bundle | ||
| hl7.fhir.eu.imaging-r5 | Manifest-ImImagingStudyManifest | Manifest obligations for ImImagingStudyManifest | draft | 2025-08 | eu | hl7 | Bundle | ||
| hl7.fhir.uv.pharm-quality | Bundle-product-manufacturing-pq | Bundle - Product Manufacturing PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.uv.emedicinal-product-info | Bundle-uv-epi | Bundle - ePI | trial-use | 2 | 2025-07 | uv | hl7 | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-organizations-pq | Bundle - Organizations PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.pl.ssidl | ssidl-bundle-labExport | Pakiet eksportu laboratorium (SSIDL) | draft | 2025-08 | pl | hl7 | Bundle | ||
| hl7.fhir.pl.ssidl | ssidl-bundle-serviceCatalog | Pakiet katalogu usług (SSIDL) | draft | 2025-08 | pl | hl7 | Bundle | ||
| hl7.fhir.cr.core | bundle-cr-core | Paquete de Recursos | draft | 0 | cgp | 2025-03 | cr | hl7 | Bundle |
| hl7.eu.fhir.gh | persona-collection | Persona Dimension Collection | active | 2025-07 | eu | hl7 | Bundle | ||
| hl7.fhir.uv.pharm-quality | Bundle-product-process-validation-pq | Bundle - Product Process Validation PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.uv.recon-ig | apix-transaction-bundle-profile | APIX Transaction Bundle Profile | draft | 2025-07 | uv | hl7 | Bundle | ||
| ch.fhir.ig.ch-epl | ch-idmp-bundle | IDMP Bundle | active | 2025-05 | ch | hl7 | Bundle | ||
| ig-ee-medication-scheme | ee-tis-medication-overview | EETISMedicationOverview | draft | 2024-02 | ee | Bundle | |||
| hl7.fhir.eu.imaging-r5 | Report-ImReport | Report obligations for ImReport | draft | 2025-08 | eu | hl7 | Bundle | ||
| hl7.fhir.uv.pharm-quality | Bundle-drug-product-specification-pq | Bundle – Drug Product Specification PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-substance-specification-pq | Bundle – Drug Substance Specification PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-stability-pq | Bundle – Drug Stability PQ | active | brr | 2024-05 | uv | hl7 | Bundle | |
| ihe-fhir-pharm-medicationrecord | MedRecord | [Profile] - Medication Record | active | 2023-03 | uv | ihe | Bundle | ||
| ihe.pharm.meow | MedicationOverview | Medication Overview Bundle | active | 2025-06 | uv | ihe | Bundle | ||
| botswana.hie.fhir | lab-orders-bundle | Bundle - Lab Orders | active | 2025-05 | Bundle | ||||
| synapxe.rcm.snapshots | BundleCommunicationObservation.StructureDefinition | BundleCommunicationObservation | active | Bundle | |||||
| synapxe.rcm.snapshots | BundlePatientCarePlan.StructureDefinition | BundlePatientCarePlan | active | Bundle | |||||
| hl7.fhir.uv.order-catalog | ItemTransactionResponse | Catalog Item Transaction Request | trial-use | 2 | oo | 2025-06 | uv | hl7 | Bundle |
| hl7.fhir.uv.order-catalog | ItemTransactionRequest | Catalog Item Transaction Request | trial-use | 2 | oo | 2025-06 | uv | hl7 | Bundle |
| acs.ig.epi.pl.deu | DEUePIPLBundle | 01 DEU ePIL Bundle | draft | 2025-06 | Bundle | ||||
| hl7.fhir.eu.imaging-manifest-r5 | ImImagingStudyManifest | IM ImagingStudy Manifest | draft | 1 | 2025-07 | eu | hl7 | Bundle | |
| hl7.fhir.eu.imaging-r5 | ImImagingStudyManifest | IM ImagingStudy Manifest | draft | 1 | 2025-08 | eu | hl7 | Bundle | |
| ema.qrdvalidation | EUEpiBundle | EU EPI Bundle | draft | Bundle | |||||
| botswana.hie.fhir | process-patient-bundle | Bundle - Process Patient in FHIR | active | 2025-05 | Bundle | ||||
| ru.fhir.semd | semd-bundle | SEMD Bundle (Пакет СЭМД) | active | 2025-07 | hl7 | Bundle | |||
| hl7.fhir.uv.application-feature | FeatureCapabilityStatement | Feature Capability Statement | trial-use | 1 | fhir | 2025-05 | uv | hl7 | CapabilityStatement |
| silfhirprofileig | sghi-careplan | SGHI Care Plan | draft | 2025-07 | CarePlan | ||||
| hl7.fhir.eu.imaging-manifest-r5 | CarePlanEu | EU CarePlan | draft | 1 | 2025-07 | eu | hl7 | CarePlan | |
| hl7.fhir.eu.imaging-r5 | CarePlanEu | EU CarePlan | draft | 1 | 2025-08 | eu | hl7 | CarePlan | |
| hl7.fhir.eu.imaging-r5 | Report-EuCarePlan | Report obligations for EuCarePlan | draft | 2025-08 | eu | hl7 | CarePlan | ||
| ihe-fhir-pharm-medicationrecord | MedRecordMedicationSummaryView | [Profile] - Summary View | active | 2023-03 | uv | ihe | CarePlan | ||
| ihe.pharm.meow | MedicationTreatment | Medication Treatment | active | 2025-06 | uv | ihe | CarePlan | ||
| ihe-fhir-pharm-medicationrecord | MedRecordTreatment | [Profile] - Treatment | active | 2023-03 | uv | ihe | CarePlan | ||
| synapxe.rcm.snapshots | CarePlan.StructureDefinition | CarePlan | active | CarePlan | |||||
| ru.core | core-careteam | Core CareTeam (Бригада) | active | 2025-08 | hl7 | CareTeam | |||
| ru.fhir.semd | core-careteam | Core CareTeam (Бригада) | active | 2025-07 | hl7 | CareTeam | |||
| ru.fhir.semd | semd-careteam | SEMD CareTeam (Бригада) | active | 2025-07 | hl7 | CareTeam | |||
| ca.on.health.idms | IDMS-ChargeItemDefinition-Rebate-Profile | IDMS - ChargeItemDefinition - Rebate Definition | draft | ChargeItemDefinition | |||||
| hl7.fhir.uv.order-catalog | LabChargeItemDefinition | Laboratory Service Charge Item Definition | trial-use | 2 | oo | 2020-02 | uv | hl7 | ChargeItemDefinition |
| de.netzwerk-universitaetsmedizin.ebm-cpg | guideline-citation | Guideline Citation | draft | 2022-03 | uv | hl7 | Citation | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | recommendation-citation | Recommendation Citation | draft | 2022-03 | uv | hl7 | Citation | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | study-citation | Study Citation | draft | 2022-03 | uv | hl7 | Citation | ||
| hl7.fhir.pl.ssidl | ssidl-citation-sourceInfo | Źródło (SSIDL) | draft | 2025-08 | pl | hl7 | Citation | ||
| digi.derm | ClinicalImpression.StructureDefinition | ClinicalImpression | active | ClinicalImpression | |||||
| hl7.fhir.uv.emedicinal-product-info | ClinicalUseDefinition-contraindication-uv-epi | ClinicalUseDefinition Contraindication (ePI) | trial-use | 2 | 2025-07 | uv | hl7 | ClinicalUseDefinition | |
| hl7.fhir.uv.emedicinal-product-info | ClinicalUseDefinition-indication-uv-epi | ClinicalUseDefinition Indication (ePI) | trial-use | 2 | 2025-07 | uv | hl7 | ClinicalUseDefinition | |
| hl7.fhir.uv.emedicinal-product-info | ClinicalUseDefinition-interaction-uv-epi | ClinicalUseDefinition Interaction (ePI) | trial-use | 2 | 2025-07 | uv | hl7 | ClinicalUseDefinition | |
| hl7.fhir.uv.emedicinal-product-info | ClinicalUseDefinition-undesirableEffect-uv-epi | ClinicalUseDefinition Undesirable Effect (ePI) | trial-use | 2 | 2025-07 | uv | hl7 | ClinicalUseDefinition | |
| hl7.fhir.uv.emedicinal-product-info | ClinicalUseDefinition-warning-uv-epi | ClinicalUseDefinition Warning (ePI) | trial-use | 2 | 2025-07 | uv | hl7 | ClinicalUseDefinition | |
| ig-ee-medication-scheme | ee-tis-renal-failure-ds | EETISRenalFailureDS | draft | 2024-02 | ee | ClinicalUseDefinition | |||
| ch.fhir.ig.ch-epl | ch-idmp-clinicalusedefinition-indication | CH IDMP ClinicalUseDefinition Indication | active | 2025-05 | ch | hl7 | ClinicalUseDefinition | ||
| ig-ee-medication-scheme | ee-tis-medication-interaction | EETISMedicationInteraction | draft | 2024-02 | ee | ClinicalUseDefinition | |||
| hl7.fhir.uv.order-catalog | ContraindicationDefinition | ClinicalUseDefinition as a contraindication | trial-use | 2 | oo | 2025-06 | uv | hl7 | ClinicalUseDefinition |
| hl7.fhir.uv.order-catalog | WarningDefinition | ClinicalUseDefinition as a warning | trial-use | 2 | oo | 2025-06 | uv | hl7 | ClinicalUseDefinition |
| hl7.fhir.uv.order-catalog | IndicationDefinition | ClinicalUseDefinition as a therapeutic indication | trial-use | 2 | oo | 2025-06 | uv | hl7 | ClinicalUseDefinition |
| hl7.fhir.uv.order-catalog | InteractionDefinition | ClinicalUseDefinition as an interaction | trial-use | 2 | oo | 2025-06 | uv | hl7 | ClinicalUseDefinition |
| hl7.fhir.uv.order-catalog | UndesirableEffectDefinition | ClinicalUseDefinition as an undesirable effect | trial-use | 2 | oo | 2025-06 | uv | hl7 | ClinicalUseDefinition |
| ee.fhir.ts | tehikcodesystem | TEHIK CodeSystem profile | draft | 2025-08 | ee | CodeSystem | |||
| hl7.fhir.pl.ssidl | ssidl-codeSystem | Słownik (SSIDL) | draft | 2025-08 | pl | hl7 | CodeSystem | ||
| hl7.fhir.uv.rfi-ig | RFICommunication | RFICommunication | draft | 2025-06 | uv | hl7 | Communication | ||
| ca.on.health.idms | Profile-Communication-External | Communication External | active | Communication | |||||
| ihe.rad.idr | idr-communication | Communications for Imaging Diagnostic Reports | draft | 2024-06 | uv | ihe | Communication | ||
| ig-ee-medication-scheme | ee-tis-communication | EETISCommunication | draft | 2025-03 | ee | Communication | |||
| synapxe.rcm.snapshots | Communication.StructureDefinition | Communication | active | Communication | |||||
| hl7.fhir.us.spl | ProductSubmissionDocument | ProductSubmissionDocument | trial-use | 1 | brr | 2025-07 | us | hl7 | Composition |
| silfhirprofileig | sghi-composition | SGHI Composition | draft | 2025-07 | Composition | ||||
| hl7.fhir.eu.imaging-manifest-r5 | ImComposition | Imaging Composition | draft | 1 | 2025-07 | eu | hl7 | Composition | |
| hl7.fhir.eu.imaging-r5 | ImComposition | Imaging Composition | draft | 1 | 2025-08 | eu | hl7 | Composition | |
| hl7.fhir.eu.imaging-manifest-r5 | CompositionEu | EU Composition | draft | 1 | 2025-07 | eu | hl7 | Composition | |
| hl7.fhir.eu.imaging-r5 | CompositionEu | EU Composition | draft | 1 | 2025-08 | eu | hl7 | Composition | |
| acs.ig.epi.pl.deu | DEUePIPLCompositionPackageLeaflet | 05 DEU ePIL Composition | draft | 2025-06 | Composition | ||||
| Hl7PlBaseIg | pl-base-composition | Composition (PL) | draft | 2025-08 | hl7 | Composition | |||
| hl7.eu.fhir.gh | focusedcomposition | Focused Composition Profile | active | 2025-07 | eu | hl7 | Composition | ||
| ig-ee-medication-scheme | ee-tis-composition | EETISComposition | draft | 2024-01 | ee | Composition | |||
| hl7.fhir.cr.core | composition-cr-core | Documento Clínico | draft | 0 | cgp | 2025-03 | cr | hl7 | Composition |
| hl7.fhir.eu.imaging-r5 | Report-ImComposition | Report obligations for ImComposition | draft | 2025-08 | eu | hl7 | Composition | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | guideline | Clinical Practice Guideline | draft | 2022-12 | uv | hl7 | Composition | ||
| hl7.eu.fhir.gh | SummaryData | Summary Data Profile | active | 2025-07 | eu | hl7 | Composition | ||
| hl7.fhir.uv.emedicinal-product-info | Composition-uv-epi | Composition (ePI) | trial-use | 2 | 2025-07 | uv | hl7 | Composition | |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-sp4151 | eCTD Specification | trial-use | 2 | brr | 2025-07 | us | hl7 | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32p32 | eCTD Batch Formula | trial-use | 2 | brr | 2025-07 | us | hl7 | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32p55 | eCTD Product Characterisation of Impurities | trial-use | 2 | brr | 2025-07 | us | hl7 | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32p10 | eCTD Product Description and Composition | trial-use | 2 | brr | 2025-07 | us | hl7 | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32s23 | eCTD Substance Control of Materials | trial-use | 2 | brr | 2025-07 | us | hl7 | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32s10 | eCTD Substance General Information | trial-use | 2 | brr | 2025-07 | us | hl7 | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32s3 | eCTD Substance Characterisation | trial-use | 2 | brr | 2025-07 | us | hl7 | Composition |
| ihe-fhir-pharm-medicationrecord | MedRecord-comp | [Profile] - Structure Composition for Medication Record | active | 2023-03 | uv | ihe | Composition | ||
| ihe.pharm.meow | MedicationOverviewComposition | Medication Overview Composition | active | 2025-06 | uv | ihe | Composition | ||
| hl7.fhir.uv.pharm-quality | Composition-drug-pq | Composition - Drug PQ | active | brr | 2024-05 | uv | hl7 | Composition | |
| hl7.fhir.uv.order-catalog | Catalog | Catalog | draft | oo | 2025-06 | uv | hl7 | Composition | |
| hl7.fhir.uv.order-catalog | CatalogHeader | Catalog Header | draft | oo | 2025-06 | uv | hl7 | Composition | |
| ema.qrdvalidation | EUEpiCompositionAnnexII | EU EPI Composition AnnexII documents | draft | Composition | |||||
| ema.qrdvalidation | EUEpiCompositionCAP | EU EPI Composition for documents in CAP authorized medicines | draft | Composition | |||||
| ema.qrdvalidation | EUEpiCompositionLabeling | EU EPI Composition Labelling documents | draft | Composition | |||||
| ema.qrdvalidation | EUEpiCompositionNAPMRPDCP | EU EPI Composition for documents in NAP-MRP-DCP authorized medicines | draft | Composition | |||||
| ema.qrdvalidation | EUEpiCompositionPackageLeaflet | EU EPI Composition Package Leaflet documents | draft | Composition | |||||
| ema.qrdvalidation | EUEpiCompositionSmPC | EU EPI Composition for SmPC documents | draft | Composition | |||||
| eu.epi.february2025b | EUEpiComposition | 02 EU EPI Composition (General) | active | Composition | |||||
| ema.qrdvalidation | EUQRD-CAP-template-new-Annex-II-en | QRD template validation profile. | draft | Composition | |||||
| ema.qrdvalidation | EUQRD-CAP-template-new-Labeling-en | QRD template validation profile. | draft | Composition | |||||
| ema.qrdvalidation | EUQRD-CAP-template-new-Package-Leaflet-en | QRD template validation profile. | draft | Composition | |||||
| ema.qrdvalidation | EUQRD-CAP-template-new-SmPC-en | QRD template validation profile. | draft | Composition | |||||
| ema.qrdvalidation | EUQRD-NAP-template-new-Common-Labeling-en | QRD template validation profile. | draft | Composition | |||||
| ema.qrdvalidation | EUQRD-NAP-template-new-Common-Package-Leaflet-en | QRD template validation profile. | draft | Composition | |||||
| ema.qrdvalidation | EUQRD-NAP-template-new-Common-SmPC-en | QRD template validation profile. | draft | Composition | |||||
| ru.core | core-composition | Core Composition (Документ) | active | 2025-08 | hl7 | Composition | |||
| ru.fhir.semd | core-composition | Core Composition (Документ) | active | 2025-07 | hl7 | Composition | |||
| ru.fhir.semd | pli-semd-composition | PLI SEMD Composition (Состав СЭМД ПЛИ) | active | 2025-07 | hl7 | Composition | |||
| ru.fhir.semd | semd-composition | SEMD Composition (Состав СЭМД) | active | 2025-07 | hl7 | Composition | |||
| silth.fhir.th.mophpc1 | mophpc-composition-visit | MoPH-PC Visit Composition | active | 2023-09 | Composition | ||||
| silfhirprofileig | sghi-condition | SGHI Condition | draft | 2025-07 | Condition | ||||
| hl7.fhir.eu.imaging-manifest-r5 | ConditionEu | EU Condition | draft | 1 | 2025-07 | eu | hl7 | Condition | |
| hl7.fhir.eu.imaging-r5 | ConditionEu | EU Condition | draft | 1 | 2025-08 | eu | hl7 | Condition | |
| ihe.rad.idr | idr-patient-history-condition | Past diagnosis of patient in Imaging Diagnostic Report | draft | 2024-06 | uv | ihe | Condition | ||
| ihe.rad.idr | idr-impression-condition | Impression as Condition | draft | 2024-06 | uv | ihe | Condition | ||
| hl7.fhir.cr.core | condition-cr-core | Condición | draft | 0 | cgp | 2025-03 | cr | hl7 | Condition |